195 related articles for article (PubMed ID: 36637184)
21. Bleomycin-mediated electrochemotherapy of metastatic melanoma.
Glass LF; Pepine ML; Fenske NA; Jaroszeski M; Reintgen DS; Heller R
Arch Dermatol; 1996 Nov; 132(11):1353-7. PubMed ID: 8915314
[TBL] [Abstract][Full Text] [Related]
22. Electrochemotherapy of cutaneous metastases of melanoma--a case series study and systematic review of the evidence.
Kis E; Oláh J; Ócsai H; Baltas E; Gyulai R; Kemény L; Horvath AR
Dermatol Surg; 2011 Jun; 37(6):816-24. PubMed ID: 21605245
[TBL] [Abstract][Full Text] [Related]
23. Electrochemotherapy a novel approach to the treatment of metastatic nodules on the skin and subcutaneous tissues.
Giardino R; Fini M; Bonazzi V; Cadossi R; Nicolini A; Carpi A
Biomed Pharmacother; 2006 Sep; 60(8):458-62. PubMed ID: 16930935
[TBL] [Abstract][Full Text] [Related]
24. Electrochemotherapy for advanced cutaneous angiosarcoma: A European register-based cohort study from the International Network for Sharing Practices of electrochemotherapy (InspECT).
Campana LG; Kis E; Bottyán K; Orlando A; de Terlizzi F; Mitsala G; Careri R; Curatolo P; Snoj M; Sersa G; Valpione S; Quaglino P; Mowatt D; Brizio M; Schepler H
Int J Surg; 2019 Dec; 72():34-42. PubMed ID: 31618680
[TBL] [Abstract][Full Text] [Related]
25. Calcium Electroporation versus Electrochemotherapy with Bleomycin in an In Vivo CAM-Based Uveal Melanoma Xenograft Model.
Tsimpaki T; Anastasova R; Liu H; Seitz B; Bechrakis NE; Berchner-Pfannschmidt U; Kraemer MM; Fiorentzis M
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256012
[TBL] [Abstract][Full Text] [Related]
26. Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases.
Ricotti F; Giuliodori K; Cataldi I; Campanati A; Ganzetti G; Ricotti G; Offidani A
Dermatol Ther; 2014; 27(3):148-52. PubMed ID: 24903471
[TBL] [Abstract][Full Text] [Related]
27. Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency.
Rezaee Z; Yadollahpour A; Rashidi S; Kunwar PS
Curr Drug Targets; 2017 Nov; 18(16):1893-1903. PubMed ID: 28641523
[TBL] [Abstract][Full Text] [Related]
28. Electrochemotherapy to Metastatic Spinal Melanoma: A Novel Treatment of Spinal Metastasis?
Gasbarrini A; Campos WK; Campanacci L; Boriani S
Spine (Phila Pa 1976); 2015 Dec; 40(24):E1340-6. PubMed ID: 26274530
[TBL] [Abstract][Full Text] [Related]
29. Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin.
Rodríguez-Cuevas S; Barroso-Bravo S; Almanza-Estrada J; Cristóbal-Martínez L; González-Rodríguez E
Arch Med Res; 2001; 32(4):273-6. PubMed ID: 11440782
[TBL] [Abstract][Full Text] [Related]
30. Electrochemotherapy and Other Clinical Applications of Electroporation for the Targeted Therapy of Metastatic Melanoma.
Cucu CI; Giurcăneanu C; Popa LG; Orzan OA; Beiu C; Holban AM; Grumezescu AM; Matei BM; Popescu MN; Căruntu C; Mihai MM
Materials (Basel); 2021 Jul; 14(14):. PubMed ID: 34300902
[TBL] [Abstract][Full Text] [Related]
31. Conjunctival melanoma and electrochemotherapy: preliminary results using 2D and 3D cell culture models in vitro.
Fiorentzis M; Katopodis P; Kalirai H; Seitz B; Viestenz A; Coupland SE
Acta Ophthalmol; 2019 Jun; 97(4):e632-e640. PubMed ID: 30548215
[TBL] [Abstract][Full Text] [Related]
32. The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro.
Scuderi M; Rebersek M; Miklavcic D; Dermol-Cerne J
Radiol Oncol; 2019 Jun; 53(2):194-205. PubMed ID: 31194692
[TBL] [Abstract][Full Text] [Related]
33. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis.
Caracò C; Mozzillo N; Marone U; Simeone E; Benedetto L; Di Monta G; Di Cecilia ML; Botti G; Ascierto PA
BMC Cancer; 2013 Dec; 13():564. PubMed ID: 24289268
[TBL] [Abstract][Full Text] [Related]
34. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases.
Jarm T; Cemazar M; Miklavcic D; Sersa G
Expert Rev Anticancer Ther; 2010 May; 10(5):729-46. PubMed ID: 20470005
[TBL] [Abstract][Full Text] [Related]
35. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels.
Markelc B; Sersa G; Cemazar M
PLoS One; 2013; 8(3):e59557. PubMed ID: 23555705
[TBL] [Abstract][Full Text] [Related]
36. Impact of electrochemotherapy in metastatic cutaneous melanoma: a contemporary systematic review and meta-analysis.
Petrelli F; Ghidini A; Simioni A; Campana LG
Acta Oncol; 2022 May; 61(5):533-544. PubMed ID: 34889156
[TBL] [Abstract][Full Text] [Related]
37. Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.
Möller MG; Salwa S; Soden DM; O'Sullivan GC
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1611-30. PubMed ID: 19895245
[TBL] [Abstract][Full Text] [Related]
38. Management of cutaneous metastases using electrochemotherapy.
Matthiessen LW; Chalmers RL; Sainsbury DC; Veeramani S; Kessell G; Humphreys AC; Bond JE; Muir T; Gehl J
Acta Oncol; 2011 Jun; 50(5):621-9. PubMed ID: 21574833
[TBL] [Abstract][Full Text] [Related]
39. [Electrochemotherapy: mechanism of action and clinical results in the locoregional treatment of patients with skin cancers and superficial metastases].
Campana LG; Marconato R; Sieni E; Valpione S; Corti L; Mocellin S; Rossi CR
Recenti Prog Med; 2016 Aug; 107(8):422-33. PubMed ID: 27571558
[TBL] [Abstract][Full Text] [Related]
40. Electrochemotherapy for primary skin cancer and skin metastasis related to other malignancies.
Reinhold U
Anticancer Drugs; 2011 Sep; 22(8):711-8. PubMed ID: 21505321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
